ARCHIVES

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Breast Implants Don’t Cause Tissue Disorders, NCI Finds

October 29, 2004